Dengue 1 Live Virus Human Challenge (DENV-1-LVHC)

BIOLOGICAL2 trials

Sponsors

University of Maryland, Baltimore, Island Pharmaceuticals

Conditions

Dengue

Phase 1

ADVP005; Dengue CVD 12000 - Dengue-1-Virus Live Virus Human Challenge (DENV-1-LVHC)

CompletedNCT04786457

University of Maryland, BaltimoreDengue

Start: 2020-11-30End: 2021-07-09Updated: 2025-02-27

Phase 2

Study to Examine the Effects of Oral Fenretinide

CompletedNCT06528457

Island PharmaceuticalsDengue

Start: 2024-09-05End: 2025-07-21Updated: 2025-10-24

Related Papers

Efficacy and immunogenicity following dengue virus-1 human challenge after a tetravalent prime-boost dengue vaccine regimen: an open-label, phase 1 trial.

2024-04-2515 citations